To compare baseline characteristics, visual acuity (VA), and morphologic outcomes between eyes with retinal angiomatous proliferation (RAP) and all other eyes among patients with neovascular age-related macular degeneration (NVAMD) treated with anti vascular endothelial growth factor (VEGF) drugs.
To compare baseline characteristics, visual acuity (VA), and morphologic outcomes between eyes with hard exudate (HE) at baseline and all other eyes among patients with neovascular age-related macular degeneration (NVAMD) treated with anti vascular endothelial growth factors (VEGFs).
To compare baseline characteristics, treatment frequency, visual acuity (VA), and morphologic outcomes of eyes with >50% of the lesion composed of blood (B50 group) versus all other eyes (Other group) enrolled in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
Overall, we saw no evidence of improvement in metabolic and morphologic outcomes with either creatine supplementation or exercise.
Interestingly, their results indicated better functional and morphologic outcomes in young adults (age 18 39 years) as compared to the paediatric age group.
Although it is today in its infancy, it has the potential to accurately simulate the operative experience for surgical planning, with improved morphologic outcomes, patient-specific biomechanical modeling to allow functional assessment of the various outcomes, and accurate simulation for surgical resident training.
In contrast, Aroclor 1254 exposure did not induce the same morphologic outcomes as DES.
To evaluate the functional and morphologic outcome of Descemet membrane endothelial keratoplasty (DMEK) combined with phacoemulsification and intraocular lens implantation in patients suffering from endothelial dysfunction and cataract.
To evaluate the effect of preimplantation genetic screening (PGS) on morphologic outcome in children.
The selection of the parameters should be based on the scientific hypothesis or question together with the current knowledge on the morphologic outcome of the investigated disease model.
